J&J Reports Q2 Adjusted EPS $2.77 Versus IBES Estimate $2.68

July 16 (Reuters) - Johnson & Johnson JNJ.N:

• J&J Q2 ADJUSTED EPS $2.77 VERSUS IBES ESTIMATE $2.68

• J&J Q2 SALES $23.74 BILLION VERSUS IBES ESTIMATE $22.84 BILLION

• J&J Q2 STELARA SALES $1.65 BILLION VERSUS IBES ESTIMATE $1.81 BILLION

• J&J Q2 DARZALEX SALES $3.54 BILLION VERSUS IBES ESTIMATE $3.38 BILLION

• J&J OUTLOOK FY ADJUSTED EPS REPORTED $10.80 - $10.90

• J&J OUTLOOK FY ESTIMATED REPORTED SALES $93.2 BILLION - $93.6 BILLION

• FY2025 EARNINGS PER SHARE VIEW $10.64, REVENUE VIEW $91.45 BILLION -- LSEG IBES DATA

Source text: [ID:]

Further company coverage: JNJ.N